Publication | Open Access

Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD)

Psychoactive DrugFunctional SelectivityAddictionNicotinePharmacologyNicotine Addiction-12-Triethylammonium-dodecane DibromidePharmacotherapyMedicineDrug Discovery